Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 163,488 | 205,530 | 236,284 | 256,146 | 329,666 |
| Marketable Securities | 99,042 | 99,696 | 5 | 10,031 | 64,130 |
| Receivables | 1,016 | 790 | 887 | 931 | 756 |
| TOTAL | $268,444 | $310,301 | $240,998 | $271,005 | $400,008 |
| Non-Current Assets | |||||
| PPE Net | 6,093 | 5,960 | 6,271 | 6,699 | 7,172 |
| Investments And Advances | 0 | 0 | 99,969 | 99,914 | 0 |
| Intangibles | 1,933 | 1,970 | 2,006 | 2,043 | 2,079 |
| Other Non-Current Assets | 20,355 | 21,180 | 21,989 | 22,779 | 24,899 |
| TOTAL | $28,381 | $29,110 | $130,235 | $131,435 | $34,150 |
| Total Assets | $296,825 | $339,411 | $371,233 | $402,440 | $434,158 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,721 | 2,818 | 1,516 | 1,755 | 2,582 |
| Accrued Expenses | 31,032 | 34,236 | 25,167 | 19,253 | 18,831 |
| TOTAL | $102,766 | $77,870 | $99,772 | $93,377 | $98,049 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 70,013 | 40,816 | 73,089 | 72,369 | 76,636 |
| Other Non-Current Liabilities | 17,077 | 18,056 | 19,017 | 19,921 | 20,807 |
| TOTAL | $125,865 | $262,000 | $159,787 | $178,110 | $190,087 |
| Total Liabilities | $228,631 | $339,870 | $259,559 | $271,487 | $288,136 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,398 | 65,393 | 65,249 | 65,157 | 65,011 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -557,609 | -623,562 | -507,496 | -484,912 | -465,669 |
| Other shareholders' equity | -919 | -242 | 52 | 15 | -43 |
| TOTAL | $68,194 | $-459 | $111,674 | $130,953 | $146,022 |
| Total Liabilities And Equity | $296,825 | $339,411 | $371,233 | $402,440 | $434,158 |